2[s_discriminator] AND (phs001597.v1.p1[s_ancestor] AND (2[s_discrimin - dbGaP - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Search results

Items: 1 to 20 of 22

<< First< Prev

Page of 2

Search results: x Variables, w Analyses, x Documents, and z Datasets in x Studies

Studies (x)
Variables (y)
Documents (y)
Analyses (w)
Datasets (w)

Clinical Variable	Dataset	Variable Description	Variable ID
SUBJECT_ID Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	De-identified subject ID	phv00388811.v1.p1
SUBJECT_ID Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject Subject ID, subject source, source subject ID, and consent group of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Subject ID	phv00388802.v1.p1
PRHPT Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	History of hypertension at baseline	phv00388821.v1.p1
BODY_SITE Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample_Attributes Sample ID, body site where sample was obtained, histological type of sample, tumor status of sample, and analyte type of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Body site where sample was collected	phv00388824.v1.p1
height Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Height	phv00388818.v1.p1
cycle Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Treatment cycle of maximum grade hypertension event	phv00388813.v1.p1
sex Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Sex	phv00388816.v1.p1
SAMPLE_USE Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample Subject ID, sample ID, sample source, source sample ID, and sample use variable of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Sample Use	phv00388810.v1.p1
SAMPLE_ID Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample_Attributes Sample ID, body site where sample was obtained, histological type of sample, tumor status of sample, and analyte type of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	De-identified sample ID	phv00388823.v1.p1
CONSENT Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject Subject ID, subject source, source subject ID, and consent group of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Consent group as determined by DAC	phv00388803.v1.p1
IS_TUMOR Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample_Attributes Sample ID, body site where sample was obtained, histological type of sample, tumor status of sample, and analyte type of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Tumor status	phv00388826.v1.p1
race Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Race	phv00388814.v1.p1
HISTOLOGICAL_TYPE Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample_Attributes Sample ID, body site where sample was obtained, histological type of sample, tumor status of sample, and analyte type of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Cell or tissue type or subtype of sample	phv00388827.v1.p1
SAMPLE_ID Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample Subject ID, sample ID, sample source, source sample ID, and sample use variable of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Sample ID	phv00388807.v1.p1
BMI Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Body mass index	phv00388820.v1.p1
age Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Age	phv00388817.v1.p1
diabetes Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	History of diabetes at baseline	phv00388822.v1.p1
ANALYTE_TYPE Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Sample_Attributes Sample ID, body site where sample was obtained, histological type of sample, tumor status of sample, and analyte type of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Analyte type	phv00388825.v1.p1
weight Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Weight	phv00388819.v1.p1
AFFECTION_STATUS Genomic Analysis of Bevacizumab-induced Hypertension	Bevacizumab_Hypertension_Subject_Phenotypes Subject ID, age, race, ethnicity, sex, affection status, BMI, treatment cycle of maximum grade hypertension, history of diabetes, and height/weight of participants with or without of Bevacizumab-induced hypertension and involved in the \"Genomic Analysis of Bevacizumab-induced Hypertension\" project.	Case control status for bevacizumab-induced hypertension	phv00388812.v1.p1

<< First< Prev

Page of 2

Supplemental Content

Filter your results:

All (22)
disease (0)
dbgap_type_studies (0)
Studies having SRA data (22)
SHARE project (0)

Manage Filters

Find related data

Recent activity

Clear Turn Off Turn On

2[s_discriminator] AND (phs001597.v1.p1[s_ancestor] AND (2[s_disc... (22)
2[s_discriminator] AND (phs001597.v1.p1[s_ancestor] AND (2[s_discriminator] OR (1[s_discriminator] AND 1[s_has_variable])))
Search

dbGaP
Assembly for Nucleotide (Select 2212750713) (1)
Assembly

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Getting Started

Important Links